LONDON – A U.K. enquiry into the moral and ethical issues raised by genome editing has concluded existing regulations provide sufficient oversight for the majority of applications but that its potential uses in treating inherited diseases by altering the germline in humans, and to increase production in livestock, requires urgent scrutiny.